Phase I results move Alzheimer’s candidate drug aducanumab into phase III trialsDecember 19, 2016Alzheimer's & CognitionNeurologyGeriatrics
Sigma-1 agonist presses forward after positive results in small Alzheimer’s trialDecember 13, 2016Alzheimer's & CognitionNeurologyGeriatrics
Statins protect against Alzheimer’s in most patientsDecember 12, 2016Alzheimer's & CognitionGeriatrics
Two-test sequence identifies sporadic Creutzfeldt-Jakob with 100% sensitivity, specificityDecember 12, 2016Alzheimer's & CognitionNeurology
TauRx still rooting for its methylene blue AD drug, despite controversial study resultsDecember 10, 2016Alzheimer's & CognitionNeurologyGeriatrics
After full data release, experts say failed Alzheimer’s trial EXPEDITION 3 offers hopeful signalsDecember 9, 2016Alzheimer's & CognitionNeurologyGeriatrics
Legislators commit to bipartisan support of Alzheimer’s fundingDecember 1, 2016Alzheimer's & CognitionGeriatricsNeurology
Antiamyloid solanezumab fails to slow decline in mild Alzheimer’sNovember 23, 2016Alzheimer's & CognitionGeriatricsNeurology
ADT not associated with increased risk of dementia in larger studyNovember 21, 2016NeurologyAlzheimer's & Cognition
VIDEO: Blood pressure and LDL lowering in elderly do not slow cognitive declineNovember 14, 2016Alzheimer's & CognitionGeriatrics
Aerobic exercise improves depression-related cognitive impairmentNovember 12, 2016DepressionAlzheimer's & Cognition
Home-based intervention improves cognitive impairment in cancer survivorsNovember 2, 2016Anxiety DisordersAlzheimer's & Cognition
Blood pressure changes and persistent hypertension elevate dementia riskNovember 1, 2016Alzheimer's & CognitionNeurologyGeriatrics
Amyloid PET scans may have clinical utility in patients with cognitive impairmentOctober 31, 2016Alzheimer's & CognitionNeurologyGeriatrics
